IL-32 as a potential biomarker and therapeutic target in cardiovascular disease.
Saved in:
| Title: | IL-32 as a potential biomarker and therapeutic target in cardiovascular disease. |
|---|---|
| Authors: | Qiu L; Guangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences, Nanning, China., Ye J; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China., Liu L; Guangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences, Nanning, China., Ji Q; Guangxi Chest Pain Center, and Department of Cardiology, The People's Hospital of Guangxi Zhuang Autonomous Region, Institute of Cardiovascular Diseases, Guangxi Academy of Medical Sciences, Nanning, China. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Apr 22; Vol. 17, pp. 1755759. Date of Electronic Publication: 2026 Apr 22 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1755759 |
